Evaro, an NHS-licensed digital healthcare platform, has announced the closing of a $25 million Series A funding round led by AlbionVC. Simplyhealth Ventures, Exceptional Ventures, Cornerstone VC, and BBI also participated.

Objective: Digital Healthcare for All

Founded by medical professionals, Evaro provides infrastructure that enables consumer brands to offer regulated digital healthcare services directly to their customers. The platform supports treatment across more than 80 conditions and has served over two million patients to date.

Infrastructure and Services

Evaro’s infrastructure includes asynchronous consultations, remote diagnostics, prescribing, dispensing, and aftercare. It can be integrated into existing digital platforms within a short timeframe, enabling partners to add healthcare services with limited implementation effort, generating new revenue streams and increased customer engagement.

Addressing Healthcare System Challenges

The funding comes amid increasing pressure on primary care in the UK, driven by extended waiting times for GP appointments. Evaro aims to help address this demand by expanding access to regulated digital healthcare services.

Future Prospects

The company plans to broaden its reach and further develop its healthcare-as-a-service offering in the UK market.